Cipla Limited — Nifedipine Exporter Profile
Indian Pharmaceutical Exporter · #1 for Nifedipine · $5.2M export value · DGFT Verified
Cipla Limited is the #1 Indian exporter of Nifedipine with $5.2M in export value and 123 verified shipments. Cipla Limited holds a 17.2% market share in Nifedipine exports across 6 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Nifedipine Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Nifedipine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.7M | 39 | 40.1% |
| PORTUGAL | $1.1M | 38 | 26.6% |
| SOUTH AFRICA | $1.1M | 30 | 24.8% |
| TRINIDAD AND TOBAGO | $135.1K | 6 | 3.1% |
| TRINIDAD & TOBAGO | $117.1K | 6 | 2.7% |
| FRANCE | $61.2K | 3 | 1.4% |
| DOMINICAN REPUBLIC | $50.0K | 1 | 1.2% |
Cipla Limited exports Nifedipine to 7 countries. The largest destination is CANADA accounting for 40.1% of Cipla Limited's Nifedipine shipments, followed by PORTUGAL (26.6%) and SOUTH AFRICA (24.8%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Nifedipine from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PHARMASCIENCE INC | CANADA | $1.0M | 25 |
| MEDPRO PHARMACEUTICA (PTY) LTD | SOUTH AFRICA | $638.0K | 15 |
| GENERIS FARMACEUTICA, SA | PORTUGAL | $572.9K | 15 |
| PHARMASCIENCE INC ,- | CANADA | $479.6K | 10 |
| GENERIS FARMACEUTICA SA | PORTUGAL | $267.7K | 6 |
| PHYSICIANS PHARMACEUTICALS LTD.,. | TRINIDAD & TOBAGO | $229.4K | 11 |
| GENERIS FARMACEUTICA, SA, | PORTUGAL | $220.0K | 15 |
| MEDPRO PHARMACEUTICA PTY LIMITED | SOUTH AFRICA | $121.3K | 3 |
| MEDPRO PHARMACEUTICA PTY LTD | SOUTH AFRICA | $120.8K | 5 |
| MEDPRO PHARMACEUTICA (PTY) LTD. | SOUTH AFRICA | $102.7K | 4 |
Cipla Limited supplies Nifedipine to 19 buyers globally. The largest buyer is PHARMASCIENCE INC (CANADA), followed by MEDPRO PHARMACEUTICA (PTY) LTD (SOUTH AFRICA) and GENERIS FARMACEUTICA, SA (PORTUGAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Nifedipine Export Value and How Much Does Cipla Limited Contribute?
India exported $22.3M worth of Nifedipine through 2,751 shipments from 331 suppliers to 117 countries, serving 666 buyers globally. Cipla Limited contributes $5.2M to this total, accounting for 17.2% of India's Nifedipine exports. Cipla Limited ships Nifedipine to 7 countries through 19 buyers.
What Is the Average Shipment Value for Cipla Limited's Nifedipine Exports?
Cipla Limited's average Nifedipine shipment value is $42.1K per consignment, based on 123 shipments totaling $5.2M. The largest destination is CANADA (40.1% of Cipla Limited's Nifedipine exports).
How Does Cipla Limited Compare to Other Indian Nifedipine Exporters?
Cipla Limited ranks #1 among 331 Indian Nifedipine exporters with a 17.2% market share. The top 3 exporters are CIPLA LIMITED ($5.2M), ALKEM LABORATORIES LIMITED ($3.6M), TORRENT PHARMACEUTICALS LTD ($3.4M). Cipla Limited processed 123 shipments to 6 destination countries.
What Nifedipine Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPALAT RETARD TAB (NIFEDIPINE 20MG) [31 | $306.0K | 7 |
| PMS - NIFEDIPINE ER 60 MG TABLET ( INV. | $200.0K | 4 |
| PMS-NIFEDIPINE ER 60MG TABLET1X100'SX2 | $190.2K | 4 |
| PMS - NIFEDIPINE ER 60 MG TABLET (INV.QTY.4368 PACK 1X100S=436800 NOS) | $129.6K | 3 |
| NIFEDIPINA GENERIS 30MG TABLETS NIFEDIPINE 30MG [PAC SIZE:2X14X15924 PAC=445872 NOS] | $91.1K | 2 |
| NIFEDIPINA GENERIS 30MG TABLETS NIFEDIPINE 30MG [PAC SIZE:2X14X15672 PAC=438816 NOS] | $89.7K | 2 |
| NIFEDIPINA GENERIS 30MG TABLETS NIFEDIPINE 30MG 2 X 14S15876 PAC X 2 X 14S=444528 NOS | $85.3K | 2 |
| PMS-NIFEDIPINE ER 60MG TABLET(1X100'S) X | $83.8K | 2 |
| PMS NIFEDIPINE ER 30MG TABLET NIFEDIPINE 30 MG EXTENDED RELEASE TABLETS PACSIZE 1X100X4555 PAC 455500 NOS | $83.0K | 2 |
| PMS NIFEDIPINE ER 30MG TABLET NIFEDIP | $83.0K | 2 |
Cipla Limited exports 88 distinct Nifedipine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPALAT RETARD TAB (NIFEDIPINE 20MG) [31 with 7 shipments worth $306.0K.
Regulatory Requirements: Exporting Nifedipine to Key Markets
What Cipla Limited must comply with to export Nifedipine to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Nifedipine Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED ★ | $5.2M | 123 | 6 | $42.1K |
| 2 | ALKEM LABORATORIES LIMITED | $3.6M | 85 | 2 | $42.6K |
| 3 | TORRENT PHARMACEUTICALS LTD | $3.4M | 95 | 9 | $36.0K |
Cipla Limited ranks #1 among 331 Indian Nifedipine exporters. Average shipment value of $42.1K compared to the market average of $67.5K. The closest competitors by value are ALKEM LABORATORIES LIMITED and TORRENT PHARMACEUTICALS LTD.
Which Indian Ports Ship Nifedipine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 407 | 14.8% |
| NHAVA SHEVA SEA (INNSA1) | 352 | 12.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 310 | 11.3% |
| JNPT/ NHAVA SHEVA SEA | 194 | 7.1% |
| JNPT | 172 | 6.3% |
| DELHI AIR | 147 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 145 | 5.3% |
| Bombay Air | 82 | 3.0% |
Geopolitical & Trade Policy Impact on Cipla Limited's Nifedipine Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Nifedipine, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nifedipine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nifedipine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 123 individual customs records matching Cipla Limited exporting Nifedipine, covering 88 formulations to 7 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 117+ countries, 666+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nifedipine Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Nifedipine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Nifedipine Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nifedipine. For current shipment-level data, contact TransData Nexus.